TITLE

Reply

AUTHOR(S)
Ostrosky-Zeichner, Luis; Marr, Kieren A.; Rex, John H.; Cohen, Stuart H.
PUB. DATE
January 2004
SOURCE
Clinical Infectious Diseases;1/15/2004, Vol. 38 Issue 2, p306
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Comments on the use of lipid formulations of amphotericin B in treating invasive fungal infections. Possibility of using continuous infusions of amphotericin B deoxycholate (AmBD); Limited comparative data supporting the efficacy of continuously infused AmBD; Link of short- and long-term toxicities with AmBD.
ACCESSION #
12083713

 

Related Articles

  • Comparative Efficacy of Amphotericin B Lipid Complex and Liposomal Amphotericin B for the Treatment of Invasive Fungal Infections in HSCT Recipients and other Immunocompromised Patient Populations with Hematologic Malignancies: A Critical Review. Mehta, Jayesh; Blake, Julie; Craddock, Charles // Open Transplantation Journal;2011, Vol. 5, p23 

    Amphotericin B is an important agent for the treatment of invasive fungal infections in immunocompromised patients because of its broad spectrum. However, its toxicities and the availability of alternative agents limit its application. Lipid-based formulations of amphotericin B, such as...

  • Complexation with Lipids Stabilizes Amphotericin B.  // Kidney;Jan/Feb99, Vol. 8 Issue 1, p38 

    Summarizes a study which sought to study the renal effects of amphotericin B lipid complex (ABLC), a lipid formulation of antifungal medication, with conventional amphotericin B (AmB) in the treatment of fungal infections. Finding that ABLC was effective as an alternative to AmB for treating...

  • Amphotericin B: Time for a New "Gold Standard". Ostrosky-Zeichner, Luis; Marr, Kieren A.; Rex, John H.; Cohen, Stuart H. // Clinical Infectious Diseases;8/1/2003, Vol. 37 Issue 3, p415 

    Describes ways in which specific lipid-based preparations of amphotericin B (AmB) are superior to amphotericin B deoxycholate (AmBD). Replacement of AmBD for primary therapy for many invasive fungal infections; Toxicities of AmBD; Indications granted to AmBD for many invasive fungal infections.

  • New drugs for systemic fungal infections. Denning, David W.; Stevens, David A. // BMJ: British Medical Journal (International Edition);8/12/89, Vol. 299 Issue 6696, p407 

    Introduces different drugs use in the treatment of systemic fungal infections. Toxicity of amphotericin B and 5-fluorocytosine; Comparison between fluconazole and itraconazole; Capability of prophylaxis with itraconzaloe to prevent infections during neutropenia.

  • Amphotericin B Lipid Complex in the Treatment of Invasive Fungal Infections: Results of the Collaborative Exchange of Antifungal Research (CLEAR), an Industry-Supported Patient Registry. Pappas, Peter G. // Clinical Infectious Diseases;5/1/2005 Supplement, Vol. 40, pS379 

    This article focuses on the use of amphotericin B lipid complex (ABLC) for the treatment of invasive fungal infections. ABLC is a composition of amphotericin B and 2 phospholipids, dimyristoylphosphatidylcholine and dimyristoylphosphatidylglycerol, in a 1:1 drug-to-lipid molar ratio. ABLC was...

  • Reduction of Nephrotoxicity Associated with Amphotericin B Deoxycholate. Johnson, James R. // Clinical Infectious Diseases;1/15/2004, Vol. 38 Issue 2, p303 

    Comments on the article on the replacement of amphotericin B deoxycholate (AmBD) with lipid formulations of amphotericin (LFAB). Link of nephrotoxicity with morbidity; Avoidance of AmBD-associated toxicities; Adoption of LFAB for routine use.

  • Controlled Trials of Amphotericin B Lipid Complex and Other Lipid-Associated Formulations. Winston, Drew J.; Schiller, Gary J. // Clinical Infectious Diseases;1/1/2000, Vol. 30 Issue 1, p236 

    Comments on an article on an uncontrolled study of the antifungal infection drug amphotericin B lipid complex (AB-LC) published in a 1998 issue of the 'Clinical Infectious Diseases' journal. Details of two trials on AB-LC not mentioned by the article; Necessity for doctors to consider...

  • Amphotericin B Lipid Complex Injection.  // AHFS Consumer Medication Information;Apr2018, p1 

    Your doctor has ordered amphotericin B lipid complex, an antifungal medication, to help treat your fungal infection. It will be added to an intravenous fluid that will drip through a needle or catheter placed in your vein for several hours, once a day. Amphotericin B lipid complex is used to...

  • Comparison of Efficacy of Amphotericin B and Itraconazole in Chronic Invasive Fungal Sinusitis. Mehta, Rupa; Panda, Naresh; Mohindra, Satyawati; Chakrabarti, Arunaloke; Singh, Paramjeet // Indian Journal of Otolaryngology & Head & Neck Surgery;Aug2013 Supplement, Vol. 65, p288 

    Management of invasive fungal sinusitis includes both surgery and antifungal chemotherapy. To compare the efficacy of amphotericin B and itraconazole used alone in the management of chronic invasive fungal sinusitis. A prospective randomized unblinded study was conducted in the Department of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics